Dergiler / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 4

Knowledge, misconceptions, stigma, and screening for viral hepatitis among hospital attendees in western Turkiye: a cross-sectional study

Enes Dalmanoğlu(BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-4425-5649
Emre Karataşlar(BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ)0009-0005-7866-7176
Sayfa
—
Yayın Tarihi
2026-07-16
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Resolving uncertainty through clear information from trusted health professionals may simultaneously reduce stigma and increase screening.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: We assessed knowledge, transmission-related misconceptions, stigmatising attitudes, and screening and vaccination behaviour for hepatitis A, B, and C among adults attending a university hospital in western Turkiye, and identified their independent determinants.
📊
Temel Bulgular & Veri:Methods: This cross-sectional study enrolled 240 adults (≥18 years).
💡
Sonuç & Katkı:Resolving uncertainty through clear information from trusted health professionals may simultaneously reduce stigma and increase screening.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Hepatitis B · Hepatitis C · health knowledge attitudes practice

Abstract

Aims: We assessed knowledge, transmission-related misconceptions, stigmatising attitudes, and screening and vaccination behaviour for hepatitis A, B, and C among adults attending a university hospital in western Turkiye, and identified their independent determinants. Methods: This cross-sectional study enrolled 240 adults (≥18 years). A structured questionnaire captured sociodemographic characteristics, a 15-item knowledge and transmission scale (correct, incorrect, or “don’t know”), three stigma items, and screening and vaccination practices. A knowledge score (0-15), a transmission-misconception score (0-4), and a stigma score (0-3) were analysed with Spearman correlation and multivariable regression. Results: The sample was predominantly female (59.2%), university-educated (80.4%), and 25.4% healthcare workers. The mean knowledge score was 8.73±4.72 of 15 (58.2% correct). “Don’t know” responses were frequent (mean 5.27) and strongly inversely correlated with knowledge (ρ=-0.93), whereas myth endorsement was uncommon (mean 0.50 of 4). Any stigmatising response was given by 41.2%. Knowledge was inversely associated with stigma (ρ=-0.35, p<0.001) and was its only independent predictor (adjusted odds ratio [aOR] 0.88 per point, 95% confidence interval [CI] 0.82-0.94). Ever-screening for hepatitis B and C was 46.2% and 35.0%, and full hepatitis B vaccination only 33.3%. Independent predictors of any screening included healthcare worker status (aOR 25.87), knowledge (aOR 1.21), and chronic disease (aOR 2.60). Conclusion: Even in a highly educated population, the dominant knowledge deficit was uncertainty rather than misconception, screening and vaccination uptake were suboptimal, and stigma was driven independently by knowledge rather than education or occupation. Resolving uncertainty through clear information from trusted health professionals may simultaneously reduce stigma and increase screening.

🔖

Bu Makaleye Atıf Yap

Dalmanoğlu, E., Karataşlar, E. (2026). Knowledge, misconceptions, stigma, and screening for viral hepatitis among hospital attendees in western Turkiye: a cross-sectional study. Anatolian Current Medical Journal, Volume: 8 Issue: 4. https://doi.org/10.38053/acmj.1969343

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (30)

  1. World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries. Geneva: World Health Organization; 2024.
  2. Hsu YC, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol. 2023;20(8):524-537. doi:10.1038/s41575-023-00760-9
  3. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529-538. doi:10.1016/j.jhep.2006.05.013
  4. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653-6657. doi:10.1016/j.vaccine.2010.08.037
  5. Özkan H. Epidemiology of chronic hepatitis B in Turkey. Euroasian J Hepatogastroenterol. 2018;8(1):73-74. doi:10.5005/jp-journals-10018-1264
  6. Toy M, Önder FO, Wörmann T, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis. 2011;11:337. doi:10.1186/1471-2334-11-337
  7. Tozun N, Ozdogan O, Cakaloglu Y, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect. 2015;21(11):1020-1026. doi:10.1016/j.cmi.2015.06.028
  8. Uçar M, Yılmaz A, Çelebi D, Çelebi Ö. Investigation of hepatitis B virus (HBsAg, anti-HBs) and anti-hepatitis C virus serology in Erzurum region: 2015-2023. Eurasian J Med. 2025;57(1):1-5. doi:10.5152/eurasianjmed.2025.24635
  9. Ceyhan M, Yildirim I, Kurt N, et al. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat. 2008;15(Suppl 2):69-72. doi:10.1111/j.1365-2893.2008.01034.x
  10. World Health Organization. Combating Hepatitis B and C to Reach Elimination by 2030. World Health Organization; 2016.
  11. Rajamoorthy Y, Taib NM, Munusamy S, et al. Knowledge and awareness of hepatitis B among households in Malaysia: a community-based cross-sectional survey. BMC Public Health. 2019;19(1):47. doi:10.1186/s12889-018-6375-8
  12. Chan HLY, Wong GLH, Wong VWS, Wong MCS, Chan CYK, Singh S. Questionnaire survey on knowledge, attitudes, and behaviour towards viral hepatitis among the Hong Kong public. Hong Kong Med J. 2022; 28(1):45-53. doi:10.12809/hkmj219463
  13. Kaskafetou S, Karakosta A, Sypsa V, et al. Hepatitis B, C and human immunodeficiency virus knowledge among the general Greek population: results from the Hprolipsis nationwide survey. BMC Public Health. 2022;22(1):2026. doi:10.1186/s12889-022-14353-9
  14. Eguchi H, Wada K. Knowledge of HBV and HCV and individuals’ attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan. PLoS One. 2013; 8(9):e76921. doi:10.1371/journal.pone.0076921
  15. Smith-Palmer J, Cerri K, Sbarigia U, et al. Impact of stigma on people living with chronic hepatitis B. Patient Relat Outcome Meas. 2020;11:95-107. doi:10.2147/PROM.S226936
  16. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457. doi:10.1016/S0140-6736(07)61602-X
  17. Abukaram TM, Alwan M, Alanazi AK, et al. Awareness of hepatitis B among the general population in Riyadh, Saudi Arabia. Cureus. 2025; 17(1):e77437. doi:10.7759/cureus.77437
  18. Othman B, Barakat M, Omar A, et al. Evaluation of hepatitis B knowledge, practices, and beliefs among the Jordanian population: a cross-sectional study. PLoS One. 2022;17(11):e0277186. doi:10.1371/journal.pone.0277186
  19. Farooqi WA, AlGubran LM, Abukaram TM, et al. Awareness of hepatitis C among the general population of Riyadh, KSA, in 2023: a cross-sectional study. Cureus. 2024;16(1):e51783. doi:10.7759/cureus.51783
  20. Alaridah N, Joudeh RM, Al-Abdallat H, et al. Knowledge, attitude, and practices toward hepatitis B infection among healthcare students: a nationwide cross-sectional study in Jordan. Int J Environ Res Public Health. 2023;20(5):4348. doi:10.3390/ijerph20054348
  21. Mokaya J, McNaughton AL, Burbridge L, et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection: a systematic review. Wellcome Open Res. 2018;3:29. doi:10.12688/wellcomeopenres.14273.2
  22. Zimmermann BM, Willem T, Rost M, Matthes N, Buyx A. Perceptions of stigma among patients with hepatitis B in Germany: cross-sectional survey. JMIR Form Res. 2025;9:e66379. doi:10.2196/66379
  23. Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. Chronic hepatitis B stigma in Ghana: a qualitative study with patients and providers. BMJ Open. 2019;9(6):e025503. doi:10.1136/bmjopen-2018-025503
  24. Suilik HA, Alfaqeh O, Alshrouf A, et al. Medical students’ knowledge, attitude, and practice regarding hepatitis B and C virus infections in Jordan: a cross-sectional study. Health Sci Rep. 2024;7(12):e70150. doi:10.1002/hsr2.70150
  25. van der Veen YJ, Voeten HA, de Zwart O, Richardus JH. Awareness, knowledge and self-reported test rates regarding hepatitis B in Turkish-Dutch: a survey. BMC Public Health. 2010;10:512. doi:10.1186/1471-2458-10-512
  26. Adjei CA, Stutterheim SE, Bram F, Naab F, Ruiter RAC. Correlates of hepatitis B testing in Ghana: the role of knowledge, stigma endorsement and knowing someone with hepatitis B. Health Soc Care Community. 2022;30(6):e4564-e4573. doi:10.1111/hsc.13860
  27. Ghazzawi M, Yendewa SA, James PB, et al. Assessment of knowledge, stigmatizing attitudes and health-seeking behaviors regarding hepatitis B virus infection in a pharmacy and community setting in Sierra Leone: a cross-sectional study. Healthcare (Basel). 2023;11(2):177. doi:10.3390/healthcare11020177
  28. Gürakar M, Malik M, Keskin O, Idilman R. Public awareness of hepatitis B infection in Turkey as a model of universal effectiveness in health care policy. Turk J Gastroenterol. 2014;25(3):304-308. doi:10.5152/tjg.2014.6718
  29. Aslan AT, Şaşmazer B, Ayar Y, Duran ZC, Akova M. Barriers against hepatitis B vaccination in high-risk adults: a cross-sectional study. Turk J Gastroenterol. 2022;33(5):427-433. doi:10.5152/tjg.2022.21257
  30. Sok S, Chhoung C, Sun B, et al. Knowledge of hepatitis B infection, hepatitis B vaccine, and vaccination status with its associated factors among healthcare workers in Kampot and Kep Provinces, Cambodia. BMC Infect Dis. 2024;24(1):658. doi:10.1186/s12879-024-09571-y